Buprenorphine for Human Immunodeficiency Virus/Hepatitis C Virus–coinfected Patients: Does It Serve as a Bridge to Hepatitis C Virus Therapy?

OBJECTIVES: Buprenorphine is associated with enhanced human immunodeficiency virus (HIV) treatment outcomes including increased antiretroviral therapy initiation rates, adherence, and CD4(+) cell counts among HIV-infected opioid-dependent individuals. Buprenorphine facilitates hepatitis C virus (HCV...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Taylor, Lynn E., Maynard, Michaela A., Friedmann, Peter D., MacLeod, Cynthia J., Rich, Josiah D., Flanigan, Timothy P., Sylvestre, Diana L.
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4209296/
https://ncbi.nlm.nih.gov/pubmed/22614935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/ADM.0b013e318257377f
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items